Bydureon catching on among endos but low profits expected, Amylin says
April 26 2012
Amylin said weekly diabetes shot Bydureon, launched in February, is gaining market share among influential physicians but expects the med's ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.